SAFETY AND EFFICACY OF VANDETANIB AS SYSTEMIC TREATMENT FOR PATIENTS WITH ADVANCED AND PROGRESSIVE MEDULLARY THYROID CANCER (MTC)

被引：0

作者：

Grande, E. ^{[1
]}

Martinez-Trufero, J. ^{[2
]}

Arevalo, S. ^{[3
]}

Alvarez-Escola, C. ^{[4
]}

Beltran, M. ^{[5
]}

Jimenez Fonseca, P. ^{[6
]}

Alonso-Gordoa, T. ^{[1
]}

Dalmau, E. ^{[7
]}

Duran, M. ^{[8
]}

Gallegos, I. ^{[9
]}

Manzano, J. L. ^{[10
]}

Mesia, R. ^{[11
]}

Pajares, I. ^{[12
]}

Fuentes, J. ^{[13
]}

Grau, J. J. ^{[14
]}

Reig Torras, O. ^{[14
]}

Trigo, J. M. ^{[15
]}

Pelaez, B. ^{[16
]}

Zafon, C. ^{[17
]}

Capdevila, J. ^{[18
]}

机构：

[1] Ramon & Cajal Univ Hosp, Med Oncol Dept, Madrid, Spain

[2] HU Miguel Servet, Zaragoza, Spain

[3] Hosp Donostia, Med Oncol Dept, San Sebastian, Spain

[4] La Paz Univ Hosp, Dept Endocrinol, Madrid, Spain

[5] ICO Girona, Girona, Spain

[6] Hosp Univ Cent Asturias, Serv Oncol Med, Oviedo, Spain

[7] Corp Hosp Parc Tauli, Sabadell, Spain

[8] Hosp Rey Juan Carlos, Mostoles, Spain

[9] Hosp Gen Segovia, Serv Oncol Med, Segovia, Spain

[10] ICO Hosp Germans Trias & Pujol, Barcelona, Spain

[11] Inst Catala Oncol ICO Hosp, IDIBELL Head & Neck Canc Unit, Med Oncol Dept, Barcelona, Spain

[12] Hosp Clin Lozano Blesa, Zaragoza, Spain

[13] Hosp Valme, Seville, Spain

[14] Hosp Clin Barcelona, Barcelona, Spain

[15] Hosp Univ Virgen de la Victoria, Malaga, Spain

[16] Univ Hosptial Valladolid, Valladolid, Spain

[17] Vall de Hebron Univ Hosp, Endocrinol Dept, Barcelona, Spain

[18] Vall dHebron Univ Hosp, Barcelona, Spain

来源：

ANNALS OF ONCOLOGY | 2014年 / 25卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1161P

引用

页数：1

共 50 条

[1] Retrospective analysis of the safety and efficacy of vandetanib as systemic treatment for patients with advanced and progressive medullary thyroid cancer (MTC)
Capdevila, Jaume
Martinez-Trufero, Javier
Dalmau, Elsa
Alvarez-Escala, Cristina
Beltran, Miguel
Duran, Manuel
Gallegos, Isabel
Luis Manzano, Jose
Mesla, Ricard
Pajares, Isabel
Fuentes Pradera, Jose
Grau, Juan J.
Reig, Oscar
Manuel Trigo, Jose
Grande, Enrique
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[2] Efficacy and safety of vandetanib for patients with advanced and progressive medullary thyroid cancer (MTC) as systemic treatment beyond first-line therapy
Hernando Cubero, J.
Grande, E.
Jimenez Fonseca, P.
Villabona, C.
Trigo Perez, J. M.
Martinez Trufero, J.
Pajares Bernad, I.
Lopez, C.
Alonso, T.
Biarnes, J.
Ramon y Cajal, T.
Duran, M.
Grau, J. J.
Arevalo Lobera, S.
Mesia Nin, R.
Llanos, M.
Dalmau Portulas, E.
Alvarez, C.
Zafon, C.
Capdevila, J.
ANNALS OF ONCOLOGY, 2018, 29 : 476 - 476
[3] The safety and efficacy of vandetanib in the treatment of progressive medullary thyroid cancer
Fallahi, Poupak
Ferrari, Silvia Martina
Baldini, Enke
Biricotti, Marco
Ulisse, Salvatore
Materazzi, Gabriele
Miccoli, Paolo
Antonelli, Alessandro
EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (11) : 1109 - 1118
[4] AN INDIRECT TREATMENT COMPARISON OF CABOZANTINIB VERSE VANDETANIB IN PROGRESSIVE MEDULLARY THYROID CANCER (MTC)
Rinciog, C.
Myren, K. J.
Alden, M.
Diamantopoulos, A.
LeReun, C.
VALUE IN HEALTH, 2014, 17 (07) : A616 - A616
[5] Safety and efficacy of two starting doses of vandetanib in advanced medullary thyroid cancer
Hu, Mimi I.
Elisei, Rossella
Dedecjus, Marek
Popovtzer, Aron
Druce, Maralyn
Kapiteijn, Ellen
Pacini, Furio
Locati, Laura
Krajewska, Jolanta
Weiss, Richard
Gagel, Robert F.
ENDOCRINE-RELATED CANCER, 2019, 26 (02) : 241 - 250
[6] Clinical utility of vandetanib in the treatment of patients with advanced medullary thyroid cancer
Deshpande, Hari
Marler, Vicky
Sosa, Julie Ann
ONCOTARGETS AND THERAPY, 2011, 4 : 209 - 215
[7] Real-World Efficacy and Safety of Cabozantinib and Vandetanib in Advanced Medullary Thyroid Cancer
Koehler, Viktoria F.
Adam, Pia
Frank-Raue, Karin
Raue, Friedhelm
Berg, Elke
Hoster, Eva
Allelein, Stephanie
Schott, Matthias
Kroiss, Matthias
Spitzweg, Christine
THYROID, 2021, 31 (03) : 459 - 469
[8] Vandetanib in progressive and symptomatic medullary thyroid cancer
Hartmann, Milan
Faust, Michael
Chiapponi, Costanza
Alakus, Hakan
Bruns, Christiane J.
ONKOLOGE, 2020, 26 (12): : 1172 - 1174
[9] Meta-Analysis of the Efficacy and Safety Evaluation of Vandetanib in the Treatment of Medullary Thyroid Cancer
Xian, Tong-cheng
Yang, Min-ye
Zhang, Xue-lin
Wang, Jie
Luo, Yi
HORMONE AND METABOLIC RESEARCH, 2024, 56 (09) : 649 - 653
[10] Efficacy and Toxicity of Vandetanib for Advanced Medullary Thyroid Cancer Treatment in Real Life Conditions
Chougnet, Cecile N.
Borget, Isabelle
Tuthyref, Network
Schlumberger, Martin Jean
ENDOCRINE REVIEWS, 2014, 35 (03)

← 1 2 3 4 5 →